AI Helped Build a Personalized Cancer Vaccine. It Just Passed Phase 3
A personalized mRNA vaccine, designed with help from an algorithm, met its main goals in a Phase 3 melanoma trial run by Merck and Moderna.
Latest AI Lifesciences news, analysis and insights from AIM Media House
A personalized mRNA vaccine, designed with help from an algorithm, met its main goals in a Phase 3 melanoma trial run by Merck and Moderna.
Gallion Health will pilot its bill-only supply chain platform across Yale New Haven Health while co-developing new features and AI capabilities.
Healthcare is choosing caution over speed on AI-led prior authorization, and for good reason.
Summa Health is deploying AI across imaging, referrals, supply ordering and patient workflows as part of HATCo’s health system transformation plan.
Mayo Clinic appointed Arun Kumar Bhaskara-Baba as CIO as it expands AI infrastructure, clinical research and a frontier model with Microsoft.
"Our priority is AI that works inside the complexity of clinical trials."
Intermountain Health has commercially deployed Perimeter’s FDA-approved Claire system to help surgeons assess breast cancer margins during surgery.
OSF HealthCare is expanding RapidAI across 18 hospitals in Illinois and Michigan to support faster stroke imaging and care coordination.
Twelve US health systems, including Advocate Health, Cedars-Sinai and Northwell Health, have joined Aidoc to develop diagnostic AI, with results expected in 2027.
LCMC Health is partnering with Qualified Health to deploy generative AI across clinical, operational, and revenue-cycle workflows.
Hims & Hers is using AI to connect customers, clinicians, labs and support teams as it expands beyond its original telehealth model.
Doximity raised its fiscal 2027 outlook as 165 health systems adopted its AI tools, while higher AI spending weighs on near-term margins.
Evolent raised its 2026 revenue guidance after reporting 47% revenue growth in Q2, with executives pointing to an AI-led operating model and new oncology partnerships.
Astrana Health raised its 2026 EBITDA outlook after reporting strong second-quarter growth driven by its AI-native healthcare platform.
Eli Lilly and Novartis spent little time discussing quarterly earnings, focusing instead on R&D, acquisitions, and the next generation of medicines.
GenScript and Tamarind Bio have partnered to connect AI-powered molecular design with wet-lab validation, aiming to help researchers evaluate drug candidates faster.
GE HealthCare introduced new AI-enabled ultrasound platforms for breast imaging and point-of-care care, expanding automation across screening, diagnosis, and clinical imaging.
Providence is using AI to identify cancer patients who may benefit from genetic testing, helping detect inherited cancer risks earlier and improve treatment decisions.
Labcorp's Q2 results show AI is supporting consumer health, specialty diagnostics, and clinical research as the company raises its 2026 outlook.
AI agent Ana already handles more than 160,000 patient calls per month across WellSpan's network, the company said.